Protecting health care workers from tuberculosis

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 7, 2008, Pages 852-855

  Buchta, William G ^a   Swift, Melanie D ^a   Litow, Francesca K ^a   Raymond, Lawrence W ^a   Budnick, Lawrence D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAPENTINE;

BACTERIAL STRAIN; BCG VACCINATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; LUNG TUBERCULOSIS; MEDICAL EDUCATION; OCCUPATIONAL SAFETY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SURGICAL MASK; ANTIBIOTIC RESISTANCE; ARTICLE; OCCUPATIONAL EXPOSURE; ORGANIZATION AND MANAGEMENT; SAFETY; UNITED STATES;

DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; OCCUPATIONAL EXPOSURE; SAFETY MANAGEMENT; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 59849124885     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e318176c523     Document Type: Article

References (32)

1. American College of Occupational Medicine. Guidelines for employee health services in health care institutions. J Occup Med. 1986;28:518-523.
2. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1-141.
3. US Department of Labor, Occupational Safety and Health Administration. Directive Number CPL 2.106: Enforcement Procedures and Scheduling for Occupational Exposure to Tuberculosis. Washington, DC: US Department of Labor, Occupational Safety and Health Administration; 1996.
4. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON®-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005;54:49 -55.
5. Nicas M. Respiratory protection and the risk of Mycobacterium tuberculosis infection. Am J Ind Med. 1995;27:317-333.
6. Lee K, Slavcev A, Nicas M. Respiratory tuberculosis: quantitative fit test outcomes for five type N95 filtering-facepiece respirators. J Occup Environ Hyg. 2004;1:22-28.
7. Coffey CC, Lawrence RB, Campbell DL, Zhuang Z, Calvert CA, Jensen PA. Fitting characteristics of eighteen N95 filtering-facepiece respirators. J Occup Environ Hyg. 2004;1:262-271.
8. American Lung Association. The American Lung Association Conference on Reestablishing Control of Tuberculosis in the United States. Am J Respir Crit Care Med. 1996;154:251-262.
9. McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med. 1995;332: 1071-1076.
10. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med. 1992;326: 231-235.
11. Pratt R, Robison V, Navin T, Hlavsa M, Pevzner E. Trends in tuberculosis incidence-United States, 2006. MMWR Recomm Rep. 2007;56:245-250.
12. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995;332:92-98.
13. Kenyon TA, Ridzon R, Luskin-Hawk R, et al. A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med. 1997;127:32-36.
14. Bailey TC, Fraser VJ, Spitznagel EL, Dunagan WC. Risk factors for a positive tuberculin skin test among employees of an urban, midwestern teaching hospital. Ann Intern Med. 1995;122:580 -585.
15. Lardizabal A, Passannante M, Kojakali F, Hayden C, Reichman LB. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin. Chest. 2006;130:1712-1717.
16. Ashkin D, Julien J, Lauzardo M, Hollender E. Consider rifampin but be cautious. Chest. 2006;130:1638 -1640.
17. Forget EJ, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf. 2006;5:231-249.
18. Noyes J, Popay J. Directly observed therapy and tuberculosis: how can a systematic review of qualitative research contribute to improving services? A qualitative meta-synthesis. J Adv Nurs. 2007;57:227-243.
19. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2006;19:CD003343.
20. Davies YM, McCray E, Simone PM. Hospital infection control practices for tuberculosis. In: Iseman MD, Huitt GA, eds. Chest Medicine. Vol. 18: Tuberculosis. Philadelphia: WB Saunders;1997:19-33.
21. American Thoracic Society, Centers for Disease Control and Infectious Diseases Society of America. Treatment of Tuberculosis, 2003. MMWR. 2003;52(RR11):1-77.
22. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA. 1992;268(10):1280 -1286.
23. Bowden KM, McDiarmid MA. Occupationally acquired tuberculosis: what's known. J Occup Med. 1994;36(3):320 -325.
24. Centers for Disease Control and Prevention, Department of Health and Human Services. Draft Guidelines for Infection Control in Health Care Personnel. Federal Register. 1997;62:47275-47327 [September 8, 1997].
25. Cleveland JL, Kent J, Gooch BF, et al. Multidrug resistant Mycobacterium tuberculosis in an HIV dental clinic. Infect Control Hosp Epidemiol. 1995;16(1):7-11.
26. Dooley SW, Villarino ME, Lawrence M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992;267(19):2632-2634.
27. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326(23):1514 -1521.
28. Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multi-drug resistant tuberculosis to patients and health care workers. Ann Intern Med. 1995(2):122:90 -95.
29. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med. 1992;117(3):191-196.
30. Stroud LA, Tokars JI, Grieco MH, et al. Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol. 1995;16(3):141-147.
31. Wenger PN, Otten J, Breeden A, Orfas D, Beck-Sague CM, Jarvis WR. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients. Lancet. 1995;345(8944):235-240.
32. Wright A, Bai G, Barrera L, et al. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000 -2004. MMWR. 55(11): 301-305.